POTENTIAL HARMS OF THE USE OF PROTON PUMP INHIBITORS: DEBATABLE PROBLEMS

POTENTIAL HARMS OF THE USE OF PROTON PUMP INHIBITORS: DEBATABLE PROBLEMS

The paper discusses data on the high frequency of non-indicated use of proton pump inhibitors and on the manifestations of potential harms of their use.

Библиографические подробности
Главные авторы:	Yu. V. Muravyev, O. R. Bobkova
Формат:	Статья
Язык:	Russian
Опубликовано:	IMA PRESS LLC 2018-11-01
Серии:	Научно-практическая ревматология
Предметы:	proton pump inhibitors harm rheumatoid arthritis hypersensitivity reactions
Online-ссылка:	https://rsp.mediar-press.net/rsp/article/view/2634

Схожие документы

Adherence with proton pump inhibitor therapy, by continuously taking nonsteroidal anti-inflammatory drugs
по: S I Pimanov, и др.
Опубликовано: (2015-04-01)

Proton pump inhibitors overuse - consequences among patients
по: Patrycja Kmiotek, и др.
Опубликовано: (2019-08-01)

Proton pump inhibitors overuse - consequences among patients
по: Patrycja Kmiotek, и др.
Опубликовано: (2019-08-01)

Proton pump inhibitors overuse: only inappropriate prescriptions or further iatrogenic damage?
по: Mario Visconti
Опубликовано: (2015-09-01)

Proton Pump Inhibitors and Gastric Cancer
по: Seungkyung Kang, и др.
Опубликовано: (2021-09-01)

Safety and Potential Risks of Prolonged Use of Proton Pump Inhibitors
по: S.M. Tkach
Опубликовано: (2014-02-01)

Proton pump inhibitor alters Th17/Treg balance and induces gut dysbiosis suppressing contact hypersensitivity reaction in mice
по: Anna Strzępa, и др.
Опубликовано: (2024-08-01)

Omeprazole was safely reused in a rhabdomyolysis patient associated with proton pump inhibitors: A case report
по: Zhen Wang, и др.
Опубликовано: (2023-11-01)

Clinicopathologic Analysis of Proton Pump Inhibitor-Responsive Esophageal Eosinophilia in Korean Patients
Опубликовано: (2016-01-01)

Deprescribing of Inappropriately Consumed Proton Pump Inhibitors and its Clinical Consequences
по: Apoorva Rachana Kulkarni, и др.
Опубликовано: (2021-08-01)

Proton pump inhibitors to control phosphorus levels in hemodialysis patients
по: Amineh Hojati
Опубликовано: (2025-10-01)

Incidence of hypomagnesemia on proton pump inhibitors at the Huntington Veterans Affairs Medical Center – IHOP
по: Ebrahim Sabbagh, и др.
Опубликовано: (2016-07-01)

Proton pump inhibitors and dementia: what association?
по: Catarina Caetano, и др.
Опубликовано: (2023-05-01)

Proton pump inhibitors usage and the risk of cancer
по: Hubert Wróblewski, и др.
Опубликовано: (2021-08-01)

Gastroesophageal reflux disease, resistant to proton pump inhibitors
по: V. O. Kaybysheva, и др.
Опубликовано: (2011-06-01)

Proton Pump Inhibitors: Are They a Real Threat to the Patient?
по: Sofia Xavier, и др.
Опубликовано: (2018-02-01)

Proton pump inhibitors: potential cost reductions by applying prescribing guidelines
по: Cahir Caitriona, и др.
Опубликовано: (2012-11-01)

A dual role of proton pump inhibition on cancer: a critical review
по: Edizer Deniz Tuna, и др.
Опубликовано: (2023-02-01)

PPI adverse drugs reactions: a retrospective study
по: Marco Casciaro, и др.
Опубликовано: (2019-01-01)

Proton pump inhibitors induce hemolytic anemia
по: Asayil Nasser Al-Nasser, и др.
Опубликовано: (2019-01-01)

Effects of proton pump inhibitor use on the esophageal microbial community
по: Sadia Tasnim, и др.
Опубликовано: (2020-09-01)

Prescription Pattern of Proton Pump Inhibitors at Hospital Admission and Discharge
по: Verónica Gamelas, и др.
Опубликовано: (2018-05-01)

Effect of Proton Pump Inhibitors in Bronchiectatic Patients with Gastroesophageal Reflux Disease
по: Byungkyu Ahn, и др.
Опубликовано: (2016-07-01)

Influence of proton pump inhibitor therapy on intestinal inflammation assessed by fecal calprotectin in pediatric patients
по: Su Yeong Kim, и др.
Опубликовано: (2019-10-01)

Proton-pump inhibitors
по: Vasudevan G. Naidoo
Опубликовано: (2015-05-01)

The Perilous PPI: Proton Pump Inhibitor as a Cause of Clinically Significant Hypomagnesaemia
по: Yong Ting Tai, и др.
Опубликовано: (2020-04-01)

Clinical Significance of Changes in Gut Microbiome Associated with Use of Proton Pump Inhibitors
по: Tae Jun Kim, и др.
Опубликовано: (2020-09-01)

Proton-pump Inhibitors and the Risk of Dementia: A Systematic Review and Meta-analysis
по: Kyu-Tae Yoon, и др.
Опубликовано: (2021-06-01)

Meniere’s disease and the use of proton pump inhibitors
по: A Pirodda, и др.
Опубликовано: (2010-09-01)

METHOTREXATE AND PROTON PUMP INHIBITORS: ARE THERE ANY NEGATIVE PHARMACOLOGIAL EFFECTS?
по: Andrey E Karateev, и др.
Опубликовано: (2014-02-01)

25 Years of Proton Pump Inhibitors: A Comprehensive Review
по: Daniel S. Strand, и др.
Опубликовано: (2017-01-01)

Proton pump inhibitors and risk for Clostridium difficile associated diarrhea
по: Sasmita Biswal
Опубликовано: (2014-08-01)

The effect of proton pump inhibitors on glycaemic control in diabetic patients
по: Muhammad Ali Rajput, PhD, и др.
Опубликовано: (2020-06-01)

Pointing the finger at proton pump inhibitors
по: Emma L Walton
Опубликовано: (2014-08-01)

Proton pump inhibitor deprescription: A rapid review
по: Renata Rodriguez Imparato, и др.
Опубликовано: (2022-07-01)

Pharmacogenetics of proton pump inhibitors
по: M. V. Leonova
Опубликовано: (2015-12-01)

Potential adverse effects of long term use of Proton Pump Inhibitors
по: Shreyans M. Doshi, и др.
Опубликовано: (2016-07-01)

Changes in serum magnesium concentration after use of a proton pump inhibitor in patients undergoing percutaneous coronary intervention
по: Sang-Ho Park, и др.
Опубликовано: (2015-06-01)

The Positive Association between Proton Pump Inhibitors and Clostridium Difficile Infection
по: Dania Tawam, и др.
Опубликовано: (2021-03-01)

Anaphylaxis as a Rare Side Effect of Pantoprazole; a Case Report
по: Gholamreza Faridaalaee, и др.
Опубликовано: (2018-05-01)